arsenic has been researched along with cyclosporine in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (35.29) | 18.2507 |
| 2000's | 15 (44.12) | 29.6817 |
| 2010's | 6 (17.65) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Azzone, GF; Bernardi, P; Lenartowicz, E | 1 |
| Burns, LA; Fuchs, BA; Munson, AE; Spriggs, TL | 1 |
| Connern, CP; Halestrap, AP | 1 |
| Durrer, P; Richter, C; Schweizer, M | 1 |
| Farber, JL; Hoek, JB; Pastorino, JG; Serroni, A; Snyder, JW | 1 |
| Connern, CP; Halestrap, AP; Woodfield, KY | 1 |
| Durry, S; Günzel, D; Schlue, WR | 1 |
| Fan, G; Kren, BT; Rodrigues, CM; Steer, CJ; Wong, PY | 1 |
| Reinach, PS; Torres-zamorano, V; Wu, X; Yang, H | 1 |
| Bernardi, P; Fontaine, E; Ichas, F | 1 |
| Chernyak, BV | 2 |
| Berman, SB; Hastings, TG; Watkins, SC | 1 |
| Cai, X; Chen, G; Huang, Y; Jia, P; Yu, Y | 1 |
| Higashi, Y; Pallis, M; Russell, N; Turzanski, J | 1 |
| Akopova, OV; Sahach, VF; Strutyns'ka, NA; Vavilova, HL | 1 |
| Rudyk, OV; Sahach, VF; Strutyns'ka, NA; Vavilova, HL | 1 |
| Takeshita, A | 1 |
| Ishida, H | 1 |
| Dale, GL; Friese, P; Remenyi, G; Szasz, R | 1 |
| He, L; Lemasters, JJ | 1 |
| Chávez, E; García, N; Martínez-Abundis, E; Pavón, N | 1 |
| Abe, Y; Muta, K; Nakashima, Y; Ohtsuka, R; Sada, E; Tachikawa, Y; Takayanagi, R | 1 |
| Halestrap, AP; Leung, AW; Varanyuwatana, P | 1 |
| Korkach, IuP; Kotsiuruba, AV; Rudyk, OV; Sahach, VF; Vavilova, HL | 1 |
| Chen, H; Wang, Y; Xue, L; Yan, S; Zhang, QY; Zheng, SS; Zhou, B | 1 |
| Berthoux, L; Bérubé, J; Nepveu-Traversy, ME | 1 |
| Fang, B; Li, N; Liu, Y; Song, Y | 1 |
| Elmér, E; Hansson, MJ; Hatakeyama, K; Morota, S; Nishiyama, T; Suzuki, M; Taguchi, C; Tanoue, T; Uchino, H; Usui, D | 1 |
| Chen, XY; Jiang, FL; Jiao, YH; Lei, KL; Liu, Y; Pan, LL; Zhang, Q; Zhao, J | 1 |
| Chen, S; Ding, W; Pan, M; Tong, Y; Zhang, X | 1 |
| Brailovskaya, IV; Konovalova, SA; Korotkov, SM; Saris, NE | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Wilk, A; Wiszniewska, B | 1 |
4 review(s) available for arsenic and cyclosporine
| Article | Year |
|---|---|
P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
Topics: Acute Disease; Adult; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Division; Ceramides; Child; Cyclosporine; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Leukemia, Myeloid; Lovastatin; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Phenotype; Protein Kinase C; Randomized Controlled Trials as Topic; Signal Transduction; Tumor Cells, Cultured | 2002 |
[Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
Topics: Alkyl and Aryl Transferases; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Cyclosporine; Cytarabine; Daunorubicin; Drug Design; Farnesyltranstransferase; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Nucleosides; Oxides; Prognosis; Radioisotopes; Remission Induction; Tetrahydronaphthalenes; Topoisomerase Inhibitors; Tretinoin; Verapamil | 2003 |
[The research method for investigating the role of the mitochondrial permeability transition pore in cell death].
Topics: Apoptosis; Arsenicals; Calcium; Cyclosporine; Cytochromes c; Diazoxide; Humans; Ion Channels; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Necrosis; Ouabain | 2004 |
Cyclophilin-D inhibition in neuroprotection: dawn of a new era of mitochondrial medicine.
Topics: Animals; Arsenicals; Brain Injuries; Calcium; Cyclophilins; Cyclosporine; Enzyme Inhibitors; Humans; Ischemia; Mitochondria; Neuroprotective Agents; Peptidyl-Prolyl Isomerase F | 2013 |
1 trial(s) available for arsenic and cyclosporine
| Article | Year |
|---|---|
Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin.
Topics: Adipogenesis; Adult; Anemia, Aplastic; Arsenic Trioxide; Arsenicals; Blood Cell Count; Blood Transfusion; Bone Marrow; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Mesenchymal Stem Cells; Oxides; Remission Induction; Treatment Outcome; Young Adult | 2013 |
29 other study(ies) available for arsenic and cyclosporine
| Article | Year |
|---|---|
Phenylarsine oxide induces the cyclosporin A-sensitive membrane permeability transition in rat liver mitochondria.
Topics: Animals; Arsenicals; Butylated Hydroxytoluene; Calcium; Cyclosporine; Intracellular Membranes; Kinetics; Membrane Potentials; Mitochondria, Liver; Permeability; Rats | 1991 |
Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
Topics: Animals; Arsenicals; Corticosterone; Cyclosporine; Female; Gallium; Immunoglobulin M; Lymphocyte Subsets; Mice; Mifepristone; Organ Size | 1994 |
Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel.
Topics: Amino Acid Isomerases; Amino Acid Sequence; Animals; Arsenicals; Blotting, Western; Calcium; Carrier Proteins; Cyclosporine; Diamide; Electrophoresis, Polyacrylamide Gel; Intracellular Membranes; Ion Channels; Mitochondria, Liver; Molecular Sequence Data; Peptidylprolyl Isomerase; Peroxides; Rats; tert-Butylhydroperoxide | 1994 |
Phenylarsine oxide stimulates pyridine nucleotide-linked Ca2+ release from rat liver mitochondria.
Topics: 3-Iodobenzylguanidine; Animals; Arsenicals; Calcium; Cyclosporine; In Vitro Techniques; Iodobenzenes; Membrane Potentials; Mitochondria, Liver; Nucleotides; Pyridines; Rats | 1994 |
Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Animals; Arsenicals; Atractyloside; Carnitine; Cell Death; Cell Hypoxia; Cells, Cultured; Cyclosporine; Intracellular Membranes; Kinetics; Liver; Male; Membrane Potentials; Mitochondria, Liver; para-Aminobenzoates; Permeability; Potassium Cyanide; Rats; Rats, Sprague-Dawley; Rotenone; Time Factors | 1993 |
Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase.
Topics: Adenosine Diphosphate; Animals; Arsenicals; Atractyloside; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclosporine; Diamide; Intracellular Membranes; Membrane Potentials; Mitochondria; Mitochondrial ADP, ATP Translocases; Nucleotides; Oxidative Stress; Permeability; Peroxides; Rats; Reactive Oxygen Species; Sulfhydryl Reagents; tert-Butylhydroperoxide | 1997 |
Intracellular alkalinization causes Mg2+ release from intracellular binding sites in leech Retzius neurones.
Topics: Animals; Arsenicals; Bicarbonates; Binding Sites; Buffers; Carbon Dioxide; Cyclosporine; Hydrogen-Ion Concentration; Leeches; Magnesium; Membrane Potentials; Microelectrodes; Neurons; Propionates; Sodium | 1997 |
Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Topics: Animals; Apoptosis; Arsenicals; Cyclosporine; Deoxycholic Acid; Intracellular Membranes; Liver; Male; Membrane Potentials; Mitochondria, Liver; Permeability; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Ursodeoxycholic Acid | 1998 |
ETA receptor mediated inhibition of intracellular pH regulation in cultured bovine corneal epithelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Animals; Arsenicals; Calcium-Calmodulin-Dependent Protein Kinases; Cattle; Cells, Cultured; Chelating Agents; Cyclosporine; Diuretics; Egtazic Acid; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Epithelium, Corneal; Hydrogen-Ion Concentration; Immunosuppressive Agents; Intracellular Fluid; Naphthalenes; Okadaic Acid; Peptides, Cyclic; Phosphoprotein Phosphatases; Protein Kinase C; Receptors, Endothelin; Spectrometry, Fluorescence; Tetradecanoylphorbol Acetate | 1998 |
A ubiquinone-binding site regulates the mitochondrial permeability transition pore.
Topics: Animals; Arsenicals; Atractyloside; Binding Sites; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclosporine; Intracellular Membranes; Ion Channels; Mitochondria, Liver; Molecular Structure; Permeability; Porins; Quinones; Rats; Ubiquinone | 1998 |
Induction of the non-selective mitochondrial pore in lymphoid cells. 1. Permeabilized rat thymocytes.
Topics: Animals; Arsenicals; Calcimycin; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Membrane Permeability; Cyclosporine; Digitonin; Enzyme Inhibitors; In Vitro Techniques; Intracellular Membranes; Mitochondria; Oxygen Consumption; Rats; T-Lymphocytes; tert-Butylhydroperoxide; Thymus Gland; Uncoupling Agents | 1999 |
Induction of the non-selective mitochondrial pore in lymphoid cells. 2. Intact rat thymocytes.
Topics: Animals; Arsenicals; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cross-Linking Reagents; Cyclosporine; Cytosol; In Vitro Techniques; Intracellular Membranes; Membrane Potentials; Mitochondria; Permeability; Rats; T-Lymphocytes; tert-Butylhydroperoxide; Thymus Gland | 1999 |
Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria.
Topics: Animals; Arsenicals; Brain; Calcium; Clonazepam; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Intercellular Signaling Peptides and Proteins; Ion Channels; Liver; Male; Membrane Proteins; Mitochondria; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Peptides; Phosphates; Rats; Rats, Sprague-Dawley; tert-Butylhydroperoxide; Thiazepines; Wasp Venoms | 2000 |
[Diamide and cyclosporin A enhanced arsenic trioxide-induced apoptosis in NB4 cells].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cyclosporine; Diamide; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Oxides; Sulfhydryl Reagents; Tumor Cells, Cultured | 2002 |
[Effect of inductors and inhibitors of the mitochondrial permeability transition pore on its opening and release of unidentified mitochondrial factor].
Topics: Animals; Arsenicals; Cyclosporine; Guinea Pigs; In Vitro Techniques; Ion Channels; Membrane Proteins; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidative Stress; Rats; Rats, Wistar | 2003 |
[Release of unidentified substances of mitochondrial origin--evidence of mitochondrial permeability transition pore opening in the heart mitochondria of rats ].
Topics: Animals; Arsenicals; Calcium Chloride; Cyclosporine; Ion Channel Gating; Ion Channels; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Proteins; Mitochondrial Swelling; Oxidative Stress; Rats; Rats, Wistar | 2003 |
Role of mitochondrial permeability transition pore in coated-platelet formation.
Topics: Adult; Apoptosis; Arsenicals; Atractyloside; Benzimidazoles; Blood Platelets; Bongkrekic Acid; Carbocyanines; Collagen; Crotalid Venoms; Cyclosporine; Cytoplasmic Granules; Diamide; Drug Synergism; Flow Cytometry; Fluorescent Dyes; Humans; Ion Channels; Lectins, C-Type; Membrane Lipids; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Phosphatidylserines; Platelet Activation; Thrombin; Thromboplastin; Ubiquinone | 2005 |
Dephosphorylation of the Rieske iron-sulfur protein after induction of the mitochondrial permeability transition.
Topics: Animals; Arsenicals; Calcium Chloride; Cyclosporine; Electron Transport Complex III; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Iron-Sulfur Proteins; Male; Mitochondria, Liver; Mitochondrial Membranes; Mitochondrial Swelling; Permeability; Phosphoprotein Phosphatases; Phosphorylation; Proteomics; Rats; Rats, Sprague-Dawley; tert-Butylhydroperoxide | 2005 |
On the opening of an insensitive cyclosporin A non-specific pore by phenylarsine plus mersalyl.
Topics: Animals; Arsenicals; Calcium; Cross-Linking Reagents; Cyclosporine; Ethylmaleimide; Ion Channel Gating; Membrane Potential, Mitochondrial; Mersalyl; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Mitochondrial Membranes; Mitochondrial Swelling; Permeability; Porins; Protein Binding; Rats; Sulfhydryl Compounds; Sulfhydryl Reagents | 2007 |
[Successful cyclosporine treatment for thrombocytopenia after salvage therapy with arsenic trioxide therapy followed by autologous hematopoietic stem cell transplantation in acute promyelocytic leukemia].
Topics: Arsenic Trioxide; Arsenicals; Autoimmune Diseases; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Salvage Therapy; Thrombocytopenia; Transplantation, Autologous | 2007 |
The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.
Topics: Animals; Arsenicals; Benzoquinones; Cell Membrane Permeability; Cyclophilins; Cyclosporine; Dibenzocycloheptenes; Enzyme Inhibitors; Ethylmaleimide; Ion Transport; Mitochondria, Heart; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Mitochondrial Membranes; Mitochondrial Proteins; Peptidyl-Prolyl Isomerase F; Phosphate Transport Proteins; Protein Binding; Protein Conformation; Rats; Spiro Compounds | 2008 |
[Mitochondrial permeability transition pore opening inhibition by ecdysterone in heart mitochondria of aging rats].
Topics: Aging; Animals; Arsenicals; Calcium; Cyclosporine; Ecdysterone; Free Radical Scavengers; Ion Channel Gating; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxides | 2008 |
Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cyclosporine; Graft Rejection; Graft Survival; Growth Inhibitors; Heart Transplantation; Histocompatibility Testing; Immunosuppressive Agents; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Oxides; Transplantation, Homologous | 2009 |
TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors.
Topics: Animals; Aotidae; Arsenic Trioxide; Arsenicals; Cell Line; Cyclosporine; Enzyme Inhibitors; Leupeptins; Macaca mulatta; Mice; Oxides; Protein Multimerization; Proteins; Ubiquitin-Protein Ligases | 2009 |
Rat Liver Mitochondrial Dysfunction Induced by an Organic Arsenical Compound 4-(2-Nitrobenzaliminyl) Phenyl Arsenoxide.
Topics: Animals; Arsenicals; Cell Membrane Permeability; Cell Respiration; Cyclosporine; Hydrogen; Lipid Peroxidation; Membrane Fluidity; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Oxygen Consumption; Potassium; Rats | 2015 |
Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
Topics: Arsenicals; Cell Death; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclosporine; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; Humans; Models, Biological; NFATC Transcription Factors; Promoter Regions, Genetic; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-myc; RNA, Messenger; Sulfides; Transcription, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
To involvement the conformation of the adenine nucleotide translocase in opening the Tl(+)-induced permeability transition pore in Ca(2+)-loaded rat liver mitochondria.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Arsenicals; Atractyloside; Calcium; Cyclosporine; Ethylmaleimide; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Protein Conformation; Rats, Wistar; Sulfhydryl Compounds; tert-Butylhydroperoxide | 2016 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
Arsenic and Selenium Profile in Erythrocytes of Renal Transplant Recipients.
Topics: Arsenic; Cyclosporine; Drug Therapy, Combination; Erythrocytes; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Pharmaceutical Preparations; Poland; Selenium | 2020 |